The Oral Serine Protease Inhibitor WX-671 – First Experience in Patients with Advanced Head and Neck Carcinoma

This publication has 15 references indexed in Scilit:

• Inhibition of invasion and metastasis in oral cancer by targeting urokinase-type plasminogen activator receptor
  Oral Oncology, 2005
• Inhibition of the invasion capacity of carcinoma cells by WX‐UK1, a novel synthetic inhibitor of the urokinase‐type plasminogen activator system
  International Journal of Cancer, 2004
• Urokinase receptor up-regulation in head and neck squamous cell carcinoma
  Head & Neck, 2000
• The urokinase plasminogen activator system as a novel target for tumour therapy
  Fibrinolysis and Proteolysis, 2000
• The plasminogen activation system in tumor growth, invasion, and metastasis
  Cellular and Molecular Life Sciences, 2000
• Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients
  European Journal of Cancer, 1998
• Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis
  Oral Oncology, 1998
• Impaired wound healing in mice with a disrupted plasminogen gene
  Nature Medicine, 1996
• Gene Targeting and Gene Transfer Studies of the Biological Role of the Plasminogen/Plasmin System
  Thrombosis and Haemostasis, 1995
• Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer
  Fibrinolysis, 1990